RDY
Dr. Reddy's Laboratories Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IN
$11.97
−0.50%Forward multiples
Based on analyst estimates
- P/E forward
- 25.21x
- P/E 2026E
- 26.58x
- P/E 2027E
- 20.23x
- P/E 2028E
- 16.54x
- P/S forward
- 2.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- 28.44x
- PEG TTM
- 2.23x
- Price / book
- 2.46x
- Price / sales
- 2.84x
- Price / cash flow
- 23.02x
Enterprise value
- Enterprise value
- $9.9B
- EV / sales
- 2.82x
- EV / EBITDA
- 16.86x
- EV / EBIT
- 26.64x
- Market cap
- $10.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026